Detalles de la búsqueda
1.
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
Transfusion
; 42(4): 443-50, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12076291
Resultados
1 -
1
de 1
1
Próxima >
>>